MedPath

bicalutamide

These highlights do not include all the information needed to use Bicalutamide Tablets safely and effectively. See full prescribing information for Bicalutamide Tablets. Initial U.S. Approval: 1995

Approved
Approval ID

c6e9ca46-4552-4978-9d24-83ef7cadeebe

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2010

Manufacturers
FDA

Kremers Urban

DUNS: 015411751

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

bicalutamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62175-132
Application NumberANDA077995
Product Classification
M
Marketing Category
C73584
G
Generic Name
bicalutamide
Product Specifications
Route of AdministrationORAL
Effective DateJune 2, 2009
FDA Product Classification

INGREDIENTS (1)

BICALUTAMIDEActive
Quantity: 50 mg in 1 1
Code: A0Z3NAU9DP
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.